t-2 toxin has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijelogrlić, S; Bocarov-Stancić, A; Juranić, I; Juranić, Z; Kilibarda, V; Milovanović, SR; Radulović, S; Stojiljković, MP; Vuletić, N | 1 |
1 other study(ies) available for t-2 toxin and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
T-2 toxin affects proliferation of three different neoplastic cell lines.
Topics: Cell Division; Cell Survival; Growth Inhibitors; HeLa Cells; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma, Experimental; T-2 Toxin; Tumor Cells, Cultured | 1998 |